MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Movement disorders in children with neurometabolic and neurodegenerative disorders: A single-center prospective study

A. Saini, S. Khanna, N. Sankhyan (Chandigarh, India)

Meeting: 2023 International Congress

Abstract Number: 1024

Keywords: Ataxia: Clinical features, Dystonia: Genetics, Mitochondrial dysfunction

Category: Pediatric Movement Disorders

Objective: To analyze the prevalence, patterns and severity of movement disorders in children with genetically proven neurometabolic and neurodegenerative diseases.

Background: Movement disorders are often the presenting symptom in children with neurometabolic and neurodegenerative diseases. There is scarcity of data on the prevalence and patterns of movement disorder in these children.

Method: Consecutive children with a confirmed neurometabolic or neurodegenerative disorder were screened for the presence of movement disorder in the Pediatric Neurology clinic. The movements were analyzed prospectively through physical examination, patients’ videos and case records documented in patients’ files and hospital database. Their severity was analyzed on the standard severity scales.

Results: We screened n=62 children with an underlying neurometabolic or neurodegenerative disorder in the past one year. Of these, n=40 children had movement disorder (prevalence 64%). The mean age at presentation was 5.45 years (SD 3.68, range 10 months to 13 years). There was a male preponderance; n=21 (52.5%) were boys and n=19 (47.5%) were girls. The mean age of onset of the first neurological symptom was 2.5 years (SD 2.38). The mean age of onset of movement disorder was 3.09 years (SD 2.48). The most common underlying causes were mitochondrial complex 1 deficiency (n=5), glutaric aciduria type 1 (n=4) and Wilson’s disease (n=4). Generalized dystonia was the most common type of movement disorder (n=28, 70%), followed by ataxia (n=16, 40%), stereotypies (n=4, 10%), tremors (n=1, 2.5%) and myoclonus (n=1, 2.5%). The majority had a single type of movement disorders, however, n=9 children (22.5%) had more than one type of movement disorder.

Conclusion: Neurometabolic and neurodegenerative disorders are an important cause of secondary movement disorders in children. Movement disorders are seen in upto 64% of these cases. Dystonia and ataxia are the most common type and nearly one-fifth have a mixed movement disorder.

To cite this abstract in AMA style:

A. Saini, S. Khanna, N. Sankhyan. Movement disorders in children with neurometabolic and neurodegenerative disorders: A single-center prospective study [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/movement-disorders-in-children-with-neurometabolic-and-neurodegenerative-disorders-a-single-center-prospective-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/movement-disorders-in-children-with-neurometabolic-and-neurodegenerative-disorders-a-single-center-prospective-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley